- Home
- XRN vs TLRY Comparison
XRN vs TLRY Comparison
Compare XRN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRN | TLRY |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Canada |
| Employees | 30 | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.8M | 570.4M |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XRN | TLRY |
|---|---|---|
| Price | $37.57 | $3.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 74.4K | ★ 3.5M |
| Earning Date | 05-06-2026 | 04-01-2026 |
| Dividend Yield | ★ 8.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.50 | $8.79 |
| Revenue Next Year | $3.83 | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.05 | $0.55 |
| 52 Week High | $38.65 | $15.70 |
Technical Indicators
Market Signals| Indicator | XRN | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 22.50 |
| Support Level | $34.68 | $0.77 |
| Resistance Level | $38.23 | $4.85 |
| Average True Range (ATR) | 0.96 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 70.11 | 3.18 |
Price Performance
Historical ComparisonAbout XRN Chiron Real Estate Inc. Common Stock
Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.